10/1/2012 – “Bavarian Nordic Reports Preliminary Data from Phase 2 Trial of CV-301 in Metastatic Breast Cancer” press release
9/13/2012 – “Cyclacel Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement” press release
8/8/2012 – “Agenus Announces Publication of Key Data Showing Antitumor Activity of Prophage Vaccine (HSPPC-96) in Clinical Cancer Research” press release
6/21/2012 – “Idera Pharmaceuticals Reports Preclinical Mechanism of Action Data on IMO-8400, a Novel TLR Inhibitor for Autoimmune Diseases” press release
4/17/2012 – “New Phase 2 Data From Brain Cancer Study With Agenus’ Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS” press release
4/16/2012 – “Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held 16 April 2012″ press release
3/5/2012 – “Agenus Expands QS-21 License and Grants Right of First Negotiation to GlaxoSmithKline” press release
